Telangiectasia as a potential clinical marker of microvascular lesions in systemic sclerosis patients from EUSTAR data in China

Clinical and Experimental Rheumatology

Volumn 33, Issue , 2015, Pages 106-110

  Zhang, Shang Zhu ^a   Xu, Dong ^a   Li, Meng Tao ^a   Hou, Yong ^a   Wang, Qian ^a   Tian, Zhuang ^a   Liu, Yong Tai ^a   Guo, Xiao Xiao ^a   Lai, Jin Zhi ^a   Zhao, Jiu Liang ^a   Hu, Chao Jun ^a   Song, Ning ^a   Sun, Qiu Ning ^a   Zhang, Feng Chun ^a   Zhao, Yan ^a   Zeng, Xiao Feng ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Microvasculopathy; Systemic sclerosis; Telangiectasia

Indexed keywords

AUTOANTIBODY;

ADULT; ARTICLE; CHINA; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC TEST; DIGITAL PITTING; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE MARKER; ERYTHROCYTE SEDIMENTATION RATE; EUSTAR DATABASE; FACE; FEMALE; FINGER; FINGER ULCER; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENDER; HEART CATHETERIZATION; HUMAN; JOINT CONTRACTURE; LABORATORY TEST; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; RODNAN SKIN SCORE; SCORING SYSTEM; SIX-MINUTE WALK TEST; SYSTEMIC SCLEROSIS; TELANGIECTASIA; TOE; TRANSTHORACIC ECHOCARDIOGRAPHY; FACTUAL DATABASE; HYPERTENSION, PULMONARY; MICROVASCULATURE; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SCLERODERMA, SYSTEMIC; SKIN; SKIN ULCER; TELANGIECTASIS; VASCULARIZATION; VASODILATATION;

ADULT; CHINA; DATABASES, FACTUAL; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MICROVESSELS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SCLERODERMA, SYSTEMIC; SKIN; SKIN ULCER; TELANGIECTASIS; VASODILATION;

EID: 84946236891     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. GABRIELLI A, AVVEDIMENTO EV, KRIEG T: Scleroderma. N Engl J Med 2009; 360: 1989-2003.
2. LeROY EC, MEDSGER TA, Jr.: Criteria for the classification of early systemic sclerosis. J Rheumatol 2001; 28: 1573-6.
3. XU D, LI MT, HOU Y et al.: Clinical characteristics of systemic sclerosis patients with digital ulcers in China. Clin Exp Rheumatol 2013; 31: 46-9.
4. WIGLEY FM: Vascular disease in scleroderma. Clin Rev Allergy Immunol 2009; 36: 150-75.
5. STEEN VD, MEDSGER TA: Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007; 66: 940-4.
6. WALKER UA, TYNDALL A, CZIRJAK L et al.: Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis 2007; 66: 754-63.
7. TYNDALL AJ, BANNERT B, VONK M et al.: Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010; 69: 1809-15.
8. BRAVERMAN IM, KEN-YEN A: Ultrastructure and three-dimensional reconstruction of several macular and papular telangiectases. J Invest Dermatol 1983; 81: 489-97.
9. WALKER JG, STIRLING J, BEROUKAS D et al.: Histopathological and ultrastructural features of dermal telangiectasias in systemic sclerosis. Pathology 2005; 37: 220-5.
10. MUKERJEE D, St GEORGE D, KNIGHT C et al.: Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology (Oxford) 2004; 43: 461-6.
11. KRISHNA SUMANTH M, SHARMA VK, KHAITAN BK, KAPOOR A, TEJASVI T: Evaluation of oral methotrexate in the treatment of systemic sclerosis. Int J Dermatol 2007; 46: 218-23.
12. ASHIDA R, IHN H, MIMURA Y et al.: Clinical and laboratory features of Japanese patients with scleroderma and telangiectasia. Clin Exp Dermatol 2009; 34: 781-3.
13. OSTOJIC P, DAMJANOV N, PAVLOV-DOLIJANOVIC S, RADUNOVIC G: Peripheral vasculopathy in patients with systemic sclerosis: difference in limited and diffuse subset of disease. Clin Hemorheol Microcirc 2004; 31: 281-5.
14. OSTOJIC P, DAMJANOV N: Different clinical features in patients with limited and diffuse cutaneous systemic sclerosis. Clin Rheumatol 2006; 25: 453-7.
15. XU D, LI MT, HOU Y et al.: Clinical characteristics of systemic sclerosis patients with digital ulcers in China. Clin Exp Rheumatol 2013; 31: 46-9.
16. HUDSON M, FRITZLER MJ, BARON M, Canadian ScCleroderma RresSearcCh Group: Systemic sclerosis: establishing diagnostic criteria. Medicine (Baltimore) 2010; 89: 159-65.
17. van den HOOGEN F, KHANNA D, FRANSEN J et al.: 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative. Arthritis Rheum 2013; 65: 2737-47.
18. SHAH AA, WIGLEY FM, HUMMERS LK: Telangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension. J Rheumatol 2010; 37: 98-104.
19. ROBERT-THOMSON PJ, MOULD TL, WALKER JG, SMITH MD, AHERN MJ: Clinical utility of telangiectasia of hands in scleroderma and other rheumatic disorders. Asian Pac J Allergy Immunol 2002; 20: 7-12.
20. NATHAN SD, SHLOBIN OA, AHMAD S, URBANEK S, BARNETT SD: Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. Chest 2007; 131: 657-63.
21. ENNIS H, HERRICK AL, CASSIDY C, GRIFFITHS CE, RICHARDS HL: A pilot study of body image dissatisfaction and the psychological impact of systemic sclerosis-related telangiectases. Clin Exp Rheumatol 2013; 31: 12-7.
22. GOLDMAN MP: Optimal management of facial telangiectasia. Am J Clin Dermatol 2004; 5: 423-34.
23. FRECH TM, SHANMUGAM VK, SHAH AA et al.: Treatment of early diffuse systemic sclerosis skin disease. Clin Exp Rheumatol 2013; 31: 166-71.
24. POLLA LL, TAN OT, GARDEN JM, PARRISH JA: Tunable pulsed dye laser for the treatment of benign cutaneous vascular ectasia. Dermatologica 1987; 174: 11-7.
25. ANDERSON RR, PARRISH JA: Microvasculature can be selectively damaged using dye lasers: a basic theory and experimental evidence in human skin. Lasers Surg Med 1981; 1: 263-76.
26. HALACHMI S, GABARI O, COHEN S, KOREN R, AMITAI DB, LAPIDOTH M: Telangiectasis in CREST syndrome and systemic sclerosis: correlation of clinical and pathological features with response to pulsed dye laser treatment. Lasers Med Sci 2014; 29: 137-40.